UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062888
Receipt number R000072007
Scientific Title Maindofurunesu meisou de ketsueki touseki kanja no ketsuatsu o kusuri ni tayorazu kanri suru houhou ni tsuite no kousatsu
Date of disclosure of the study information 2026/09/11
Last modified on 2026/09/11 18:40:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Maindofurunesu meisou de ketsueki touseki kanja no ketsuatsu o kusuri ni tayorazu kanri suru houhou ni tsuite no kousatsu

Acronym

Maindofurunesu meisou de ketsueki touseki kanja no ketsuatsu o kusuri ni tayorazu kanri suru houhou ni tsuite no kousatsu

Scientific Title

Maindofurunesu meisou de ketsueki touseki kanja no ketsuatsu o kusuri ni tayorazu kanri suru houhou ni tsuite no kousatsu

Scientific Title:Acronym

Maindofurunesu meisou de ketsueki touseki kanja no ketsuatsu o kusuri ni tayorazu kanri suru houhou ni tsuite no kousatsu

Region

Japan


Condition

Condition

End-stage kidney failure (on dialysis)

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In patients on maintenance hemodialysis, high blood pressure and blood pressure fluctuations during dialysis are often an issue, contributing to cardiovascular events and reduced quality of life. While managing with antihypertensive drugs and salt and fluid restrictions is important, there are limited non-drug options that patients can easily take on themselves. Mindfulness meditation has been reported to reduce stress and anxiety, lower sympathetic nervous activity, and help lower blood pressure, and it might be possible to do it during the waiting time before dialysis. This study explores the feasibility and potential effects on blood pressure stabilization of audio-guided mindfulness meditation in outpatient maintenance hemodialysis patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

After obtaining consent and during the waiting time before starting dialysis, about 5 minutes of guided mindfulness meditation with an audio guide will be conducted in a quiet environment using headphones or speakers. The audio guide will focus on breathing and will not aim for religious proselytizing or promoting any particular ideology.

In the control condition, participants will listen to white noise for the same amount of time in the same environment. If possible, the mindfulness meditation condition and the control condition will be compared within the same participants.

Each condition will be conducted three times a week before dialysis, with a basic plan of about three total sessions. As needed, feasibility can be checked in healthy individuals or a small number of cases, and the intervention period and procedure can be adjusted accordingly.

Blood pressure and pulse before and after the intervention and during dialysis will be recorded within the range usually measured in routine care. In addition, increases in systolic blood pressure of 30 mmHg or more after the start of dialysis, hypotension during dialysis, symptoms, use of antihypertensive drugs, and dialysis conditions will be recorded.

As an outcome measure for the effect of mindfulness meditation, the STAI (state and trait anxiety) or Affect Grid will be used as much as possible to evaluate changes in anxiety and emotional states before and after the intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Mindfulness meditation

Interventions/Control_2

White Noise

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

90 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients receiving outpatient maintenance hemodialysis
Those who show a systolic blood pressure increase of 30 mmHg or more during dialysis, or have blood pressure instability such as hypotension during dialysis
Those who have the hearing and cognitive ability to listen to audio guidance and practice mindfulness meditation
Those who understand the study and can give written consent

Key exclusion criteria

People who have a history or current condition of mental disorders where symptoms like psychotic disorders, mania, or suicidal thoughts might worsen with mindfulness meditation.
People with severe cognitive or communication impairments.
People with hearing difficulties that make it hard to hear audio.
People who are expected to have major changes in dialysis conditions, blood pressure medications, or dry weight during the study period.
People whom the study supervisor deems inappropriate.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name takesi
Middle name
Last name nakata

Organization

Oita University

Division name

Faculty of Welfare and Health Sciences, Physical Therapy Course

Zip code

870-1124

Address

700 Danno-hara, Oita City, Oita Prefecture

TEL

090-554-6613

Email

nakata@oita-u.ac.jp


Public contact

Name of contact person

1st name takesi
Middle name
Last name nakata

Organization

Oita University

Division name

Faculty of Welfare and Health Sciences, Physical Therapy Course

Zip code

870-1124

Address

700 Danno-hara, Oita City, Oita Prefecture

TEL

090-554-6613

Homepage URL


Email

nakata@oita-u.ac.jp


Sponsor or person

Institute

Oita University

Institute

Department

Personal name



Funding Source

Organization

Oita University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Oita University

Address

700 Danno-hara, Oita City, Oita Prefecture

Tel

090-554-6613

Email

nakata@oita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 11 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 11 Day

Date of IRB


Anticipated trial start date

2026 Year 09 Month 17 Day

Last follow-up date

2026 Year 10 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 11 Day

Last modified on

2026 Year 09 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072007